Posts tagged as

Adverse Event

FDA and HCV-TARGET team up to help doctors and patients optimize hepatitis C therapy

August 30, 2013

As doctors prepare to manage an influx of new hepatitis C patients and treatment options, a collaboration among academia, industry and the FDA is poised to deliver real-world data that can help.

CTSA-based Hepatitis C Therapeutic Registry and Research Network releases first data

April 29, 2013

HCV-TARGET observes how new therapies for hepatitis C are used and managed in routine practice to inform treatment guidelines and improve safety.